Bio Green Med Solution Inc - Company Profile
Powered by 
All the sales intelligence you need on Bio Green Med Solution Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Bio Green Med Solution Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Bio Green Med Solution Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Bio Green Med Solution Clinical Trials
Determine Bio Green Med Solution Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Bio Green Med Solution Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma | GDCT0411778 | CYC-140 | Oncology | Bladder Cancer; Breast Cancer; Cutaneous T-Cell Lymphoma; Diffuse Large B-Cell Lymphoma; Hepatocellular Carcinoma; Lymphoma; Metastatic Biliary Tract Cancer; Metastatic Colorectal Cancer; Non-Small Cell Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Peripheral T-Cell Lymphomas (PTCL); Prostate Cancer; Small-Cell Lung Cancer; Solid Tumor; Triple-Negative Breast Cancer (TNBC); Unspecified B-Cell Lymphomas | Phase I/II | Ongoing, recruiting | Cyclacel Pharmaceuticals Inc |
| Efficacy of Probiotics Administration in Patients with Partly Controlled Asthma: A Randomized Controlled Trial | GDCT0365381 | Bifidobacterium infantis 35624 | Respiratory | Asthma | Phase II | Ongoing, recruiting by invitation | Phramongkutklao College of Medicine and Hospital;Royal Thai Army Medical Department |
| CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS | GDCT0356124 | fadraciclib | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia); Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Phase I | Ongoing, not recruiting | Cyclacel Pharmaceuticals Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer